{
  "abstract": "Pain perception is a vital protective mechanism.1 However, chronic pain, maladaptive and persistent, constitutes a major disease burden.2 Reliance on opioid analgesics is fraught with risks of tolerance, dependence, addiction and fatal respiratory depression, underscoring the urgent need for non-opioid alternatives.3–5",
  "authors": [
    {
      "affiliations": [
        "Genetic Skin Disease Center, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China"
      ],
      "name": "Pu Xia"
    },
    {
      "affiliations": [
        "Genetic Skin Disease Center, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China"
      ],
      "name": "Ran Mo"
    },
    {
      "affiliations": [
        "Genetic Skin Disease Center, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China"
      ],
      "name": "Linghan Hu"
    },
    {
      "affiliations": [
        "Genetic Skin Disease Center, Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, China"
      ],
      "name": "Yong Yang"
    }
  ],
  "title": "Six at Sixty. ‘No gain, no pain’: medical genetics taking Nav1.7 from target to pharmacy",
  "uid": "8a123919-0113-530f-beb3-81ad95243ae8"
}